Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.
The plasma concentration at any time during an oral or extravascular multiple-dose regimen, assuming a one-compartment model, depends on the plasma concentration Cp, the bioavailability F, the dose D0, the volume of distribution VD, the dosing interval τ, the elimination rate constant k, and n, the number of doses. The mean plasma level at steady state, which is the average concentration when the rate of drug administration equals the rate of elimination, is found using Cl, or the clearance, which inversely impacts the steady state mean plasma level: as clearance decreases, the mean plasma level at steady state increases.
Maximum (Cmax) and minimum (Cmin) drug concentrations in the body are calculated by equations incorporating factors such as dose, clearance, and dosing interval. The time to reach maximum concentration tmax and the peak plasma concentration after the nth dose can also be calculated, providing essential details for optimizing dosing regimens to maintain therapeutic efficacy while minimizing toxicity.
Understanding these pharmacokinetic principles is essential for designing effective and safe medication dosing schedules, ensuring that drugs reach therapeutic levels without causing harm due to accumulation or subtherapeutic levels due to insufficient dosing.
Drug levels in the body after multiple oral doses follow a repeating pattern of peaks and troughs, reflecting the phases of absorption and elimination.
Over time, this pattern stabilizes, forming a consistent rhythm of maximum and minimum levels, known as the steady state.
The average steady-state concentration represents the equilibrium between drug absorption and clearance.
Clearance directly influences the average steady-state level —lower clearance results in a higher average concentration.
Predicting maximum and minimum drug levels helps adjust dosing intervals for optimal therapeutic benefit.
After a single dose, the peak plasma concentration and the time it occurs are crucial factors in dosage decisions.
Drugs with a narrow therapeutic index can cause dangerous fluctuations in plasma drug levels.
Smaller, more frequent doses help minimize these fluctuations, maintaining the same average concentration while ensuring safer, lower peaks and troughs.
For many potent drugs, the dosing interval is often guided by the elimination half-life. However, for drugs like warfarin, dosing is guided by therapeutic monitoring parameters.
繁體中文
